Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2000
06/22/2000WO2000035462A1 Novel therapeutic application of low molecular weight heparin
06/22/2000WO2000035459A1 New solid metriphonate formulations
06/22/2000WO2000035450A1 Controlled/modified release oral methylphenidate formulations
06/22/2000WO2000035444A1 USE OF η-TOCOPHEROL AND ITS OXIDATIVE METABOLITE LLU-α IN THE TREATMENT OF DISEASE
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035430A2 Homer a new target of treating psychiatric disorders
06/22/2000WO2000035428A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/22/2000WO2000035423A1 Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
06/22/2000WO2000035417A1 Pharmaceutical preparation for inhalation of an opioid
06/22/2000WO2000035280A1 Exo-r-mecamylamine formulation and use in treatment
06/22/2000WO2000035279A1 Exo-s-mecamylamine formulation and use in treatment
06/22/2000WO2000008004A8 Particle-forming compositions containing fused pyrrolocarbazoles
06/22/2000WO2000002542A3 Agents with an antidepressive effect containing pramipexol and an additional antidepressant drug
06/22/2000WO1999048488A3 Methods for decreasing beta amyloid protein
06/22/2000WO1999038504A8 Pharmaceutical uses of optically pure (-)-bupropion
06/22/2000CA2393442A1 Exo-r-mecamylamine formulation and use in treatment
06/22/2000CA2362423A1 47 human secreted proteins
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355234A1 Quinoline derivatives
06/22/2000CA2355202A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000CA2355201A1 Morpholinone and morpholine derivatives and uses thereof
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2354402A1 4,5-pyrazinoxindoles as protein kinase inhibitors
06/22/2000CA2354323A1 Homer a new target of treating psychiatric disorders
06/22/2000CA2354061A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
06/22/2000CA2352570A1 Methods and compositions for treating disorders involving excitotoxicity
06/22/2000CA2351860A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
06/22/2000CA2351859A1 1,4-piperazine derivatives having 5ht1a receptor activity
06/22/2000CA2351464A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000CA2351400A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
06/22/2000CA2351385A1 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)quinoxalin-5(6h)one derivates being 5ht2c agonists
06/22/2000CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/21/2000EP1010698A1 1,2-dithiolane derivatives, their process of preparation and pharmaceutical compositions containing them
06/21/2000EP1010694A2 Spiroimidazoline derivatives and their use as alpha2-adrenergic antagonists and monoamines-reuptake blockers
06/21/2000EP1010693A1 Imidazoline derivatives, preparation and pharmaceutical compositions containing them
06/21/2000EP1010689A1 Substituted cycloheptenes, their preparation and use
06/21/2000EP1010688A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
06/21/2000EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms
06/21/2000EP1009811A2 New tissue-specific calpaines, their production and their use
06/21/2000EP1009806A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
06/21/2000EP1009804A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
06/21/2000EP1009760A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders
06/21/2000EP1009750A1 Novel (alpha-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof
06/21/2000EP1009738A1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
06/21/2000EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
06/21/2000EP1009734A1 Branched chain fatty acids, their derivatives and use in the treatment of central nervous system disorders
06/21/2000EP1009447A1 Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
06/21/2000EP1009426A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
06/21/2000EP1009412A1 Use of purine nucleosides for modulating the axonal outgrowth of central nervous system neurons
06/21/2000EP1009403A1 Method for treating schizophrenia
06/21/2000EP1009399A1 Gaba analogs to prevent and treat gastrointestinal damage
06/21/2000EP1009397A2 N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
06/21/2000EP1009396A1 Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin
06/21/2000EP1009393A2 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
06/21/2000EP1009387A1 Stabilized sustained release tramadol formulations
06/21/2000EP0785196B1 Polymorphs a and b of 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl) propyl]piperazine
06/21/2000EP0638073B1 1-piperazino-1,2-dihydroindene derivatives
06/21/2000DE19958427A1 Drug for curing migraine and the preparation method
06/21/2000DE19858593A1 (2-Phenyl-4-(phenylsulfonyl)-oxazol-5-yl)-amine therapeutic agents having 5-HT6 receptor affinity, useful for treating CNS disorders such as psychosis, schizophrenia, depression or Alzheimer's disease
06/21/2000DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors
06/21/2000DE19857716A1 Neue feste Formulierung von Metrifonat New solid formulation of metrifonate
06/21/2000CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases
06/21/2000CN1257506A Spiro-quinuclidine derivatives, their preparation and use
06/21/2000CN1257504A Salts of aromatic sulphonic acids
06/21/2000CN1257500A 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257491A 4-tetrahydropyridylpyrimidine derivatives
06/21/2000CN1257485A Azacyclooctane and heptane derivatives, their preparation and usein therapy
06/21/2000CN1257483A Substituted isoquinolines as ultra short acting neuromuscular blockers
06/21/2000CN1257482A Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist
06/21/2000CN1257429A Use of low-molecular-weight heparins for preventing and treating cerebral edemas
06/21/2000CN1257428A Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
06/21/2000CN1257072A Novel 1,2-amylic cycle disulfide, its preparation process and medicinal compoisitions containing same
06/21/2000CN1256948A Oral medicine for treating cranial nerve system disease and preparation process thereof
06/21/2000CN1256929A Traditional Chinese medicine for stopping drug-taking
06/21/2000CN1256923A Traditional Chinese medicinal composition for stopping drug taking and preparation process thereof
06/21/2000CN1053667C Inhibiting photodecomposition of 3-substituted-2-oxindoles
06/21/2000CN1053662C New tricyclic amide compounds, processes for their preparation and the pharmaceutical compositions containing same
06/21/2000CN1053587C Chinese patent medicine for treating schizophrenia
06/21/2000CN1053570C Pharmaceutical composition of piperidinoalkanol-decongestant combination preparation process
06/20/2000US6077867 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
06/20/2000US6077861 Modulators of the large-conductance calcium-activated potassium (bk) channels, therefore, useful in the treatment of ischemic stroke
06/20/2000US6077852 Administering to the patient suffering from alzheimer's disease a substituted benzothiophene derivative
06/20/2000US6077846 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
06/20/2000US6077845 As analgesic for alleviating pain
06/20/2000US6077843 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
06/20/2000US6077829 Comprising brain derived neurotrophic factor(bdnf), polyoxyethylene sorbitan monooleate as nonionic surfactant, and carrier; prevents denaturing and polymerization of bdnf; storage stability
06/20/2000US6077675 Drug screening by contacting compound with recombinant cell which expresses a nucleic acid encoding the receptor and monitoring for binding or modulation of receptor; anticonvulsants; analgesics; cognition enhancers
06/20/2000US6077539 Rapid bioavailability of metoclopramide; long acting non-steroidal antiinflammatory agent; free of ht3 receptor antagonists; side effect reduction
06/20/2000US6077510 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
06/20/2000US6077509 Given amino acid sequences that are immunodominant in humans suffering from multiple sclerosis
06/20/2000CA2215659C Morphinan hydroxamic acid compounds
06/20/2000CA2210241C Pharmaceutical composition containing cyclosporin for treating a human with nervous insult
06/20/2000CA2198536C Method of reducing tissue damage associated with ischemia
06/20/2000CA2013381C Selective adenosine receptor compounds
06/15/2000WO2000034791A1 Assays for compounds which increase phospholipase a2 activity
06/15/2000WO2000034511A2 Aβ-PEPTIDE SCREENING ASSAY
06/15/2000WO2000034477A2 Neuron-associated proteins
06/15/2000WO2000034475A2 Grnf4, a gdnf-related neurotrophic factor
06/15/2000WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders
1 ... 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 ... 1833